Login / Signup

Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies.

Isabel AugustKaterina SemendeferiMaria Carolina Marchetto
Published in: The Journal of comparative neurology (2022)
Alzheimer's disease (AD) is a progressive neurodegenerative disease that is ultimately fatal. Currently, millions of Americans are living with AD, and this number is predicted to grow with increases in the aging population. Interestingly, despite the prevalence of AD in human populations, the full AD phenotype has not been observed in any nonhuman primate (NHP) species, and it has been suggested that NHPs are immune to neurodegenerative diseases such as AD. Here, we review the typical age-related changes and pathologies in humans along with the neuropathologic changes associated with AD, and we place this information in the context of the comparative neuropathology of NHPs. We further propose the use of induced pluripotent stem cell technology as a way of addressing initial molecular processes and changes that occur in neurons and glia (in both humans and NHPs) when exposed to AD-inducing pathology prior to cell death.
Keyphrases
  • stem cells
  • cell death
  • cognitive decline
  • multiple sclerosis
  • healthcare
  • cell therapy
  • spinal cord
  • white matter
  • spinal cord injury
  • health information
  • signaling pathway
  • mild cognitive impairment
  • brain injury